Kala Bio (KALA) Total Debt (2016 - 2025)
Kala Bio's (KALA) quarterly Total Debt came in at $28.4 million in Q3 2025, down 19.15% year-over-year from $35.1 million in Q3 2024, and little changed quarter-over-quarter from $28.3 million in Q2 2025.
Analysis
Kala Bio (KALA) Total Debt (2016 - 2025) Analysis & Trends
Kala Bio has disclosed Total Debt across 10 years of filings, most recently posting $28.4 million for Q3 2025.
- In Q3 2025, Total Debt fell 19.15% year-over-year to $28.4 million; the TTM figure through Sep 2025 stood at $28.4 million (down 19.15% YoY), while the FY2024 annual figure was $30.4 million, down 10.97% from the prior year.
- Total Debt came in at $28.4 million for Q3 2025 at Kala Bio, roughly flat from $28.3 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $83.6 million in Q2 2022 to a low of $28.3 million in Q2 2025.
- Average Total Debt over 5 years is $48.7 million, with a median of $34.8 million recorded in 2024.
- Year-over-year, Total Debt gained 14.54% in 2021 and slumped 59.93% in 2023.
- Over 5 years, Total Debt stood at $82.7 million in 2021, then tumbled by 48.11% to $42.9 million in 2022, then dropped by 20.37% to $34.2 million in 2023, then retreated by 10.97% to $30.4 million in 2024, then retreated by 6.66% to $28.4 million in 2025.
- Per Business Quant data, the three most recent Total Debt figures were $28.4 million in Q3 2025, $28.3 million in Q2 2025, and $30.6 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.01 Bn | 193.02 Bn | 7.24 Bn | 62.75 Bn |
| 2 | Gilead Sciences | 179.98 Bn | 176.80 Bn | 6.22 Bn | 28.66 Bn |
| 3 | Vertex Pharmaceuticals | 131.45 Bn | 123.60 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.02 Bn | 74.03 Bn | 3.93 Bn | 1.99 Bn |
| 5 | Argenx Se | 60.35 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.69 Bn | 48.55 Bn | 52.00 Mn | 591.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.11 Bn | 29.80 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn | 8.09 Bn |
| 9 | Roivant Sciences | 29.21 Bn | 29.21 Bn | 1.16 Mn | - |
| 10 | Kala Bio | 8.44 Mn | 8.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 28.41 Mn |
| Jun 30, 2025 | 28.30 Mn |
| Mar 31, 2025 | 30.62 Mn |
| Dec 31, 2024 | 30.44 Mn |
| Sep 30, 2024 | 35.14 Mn |
| Jun 30, 2024 | 34.82 Mn |
| Mar 31, 2024 | 34.50 Mn |
| Dec 31, 2023 | 34.19 Mn |
| Sep 30, 2023 | 33.88 Mn |
| Jun 30, 2023 | 33.57 Mn |
| Mar 31, 2023 | 33.27 Mn |
| Dec 31, 2022 | 42.94 Mn |
| Sep 30, 2022 | 46.57 Mn |
| Jun 30, 2022 | 83.57 Mn |
| Mar 31, 2022 | 83.03 Mn |
| Dec 31, 2021 | 82.75 Mn |
| Sep 30, 2021 | 78.49 Mn |
| Jun 30, 2021 | 78.06 Mn |
| Mar 31, 2021 | 72.52 Mn |
| Dec 31, 2020 | 72.24 Mn |